Colorado Research Partners LLC Aurora, CO - 80016

Colorado Research Partners LLC is categorized under Commercial Medical Research in Aurora, CO and active since 2014.

Colorado Research Partners LLC was established in 2014, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Jeffrey Johnson at the company’s single location by writing to 15857 East Aberdeen Avenue, Aurora, Colorado CO 80016 or by phoning (612) 202-7174. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Colorado Research Partners LLC
Contact Person: Jeffrey Johnson
Address: 15857 East Aberdeen Avenue, Aurora, Colorado 80016
Phone Number: (612) 202-7174
Annual Revenue (USD): $100.000 to $499.999
Founded: 2014
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Colorado Research Partners LLC was started in 2014 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Jeffrey Johnson for inquiries that concern Colorado Research Partners LLC by calling the company number (612) 202-7174, as your correspondence is most welcome. Additionally, the physical location of the single location of Colorado Research Partners LLC can be found at the coordinates as well as the street address 15857 East Aberdeen Avenue in Aurora, Colorado 80016.

For its online presence, you may visit Colorado Research Partners LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.